* The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
The historical rank and industry rank for Clover Health Investments's PEG Ratio or its related term are showing as below:
BSP:CLOV34's PEG Ratio is not ranked *
in the Healthcare Plans industry.
Industry Median: 2.3 * Ranked among companies with meaningful PEG Ratio only.
Peter Lynch thinks a company with a P/E ratio equal to its growth rate is fairly valued.
Clover Health Investments (BSP:CLOV34) PEG Ratio Explanation
To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the P/E ratio divided by the growth ratio. He thinks a company with a P/E ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a P/E of 20, instead of a company growing 10% a year with a P/E of 10.
Clover Health Investments PEG Ratio Related Terms
Clover Health Investments PEG Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:CLOV34 vs PGNY, ALHC, PFHO: PEG Ratio Comparison
For the Healthcare Plans subindustry, Clover Health Investments's PEG Ratio, along with its competitors' market caps and PEG Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clover Health Investments PEG Ratio vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Clover Health Investments's PEG Ratio distribution charts can be found below:
* The bar in red indicates where Clover Health Investments's PEG Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Note: The 5-Year EBITDA Growth Rate is the 5-year average EBITDA per share growth rate. While the denominator is a percentage, we use the whole number as opposed to the decimal form for the calculation. For example, 5% would be shown as 5 as opposed to 0.05. If it's smaller than or equal to 0, then the PEG Ratio is not calculated.
Clover Health Investments (BSP:CLOV34) has a PEG Ratio of 0.00 as of Jun. 24, 2026. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Clover Health Investments and its competitors. According to the industry distribution chart, Clover Health Investments ranks #999999 out of 7 companies in the Healthcare Plans industry.
Is Clover Health Investments' PEG Ratio too high?
Clover Health Investments' current PEG Ratio is 0.00. Based on the distribution chart, Clover Health Investments ranks #999999 out of 7 companies in the Healthcare Plans industry, which is in the bottom quartile relative to peers. Overall, Clover Health Investments has a GF Score™ of 48/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Clover Health Investments' PEG Ratio compare to PGNY and ALHC?
According to the Healthcare Plans industry distribution chart, Clover Health Investments ranks #999999 out of 7 companies for PEG Ratio. This places Clover Health Investments in the lower half of its industry. The industry median PEG Ratio is 2.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PEG Ratio for a Healthcare Plans company?
The median PEG Ratio among Healthcare Plans companies is 2.30, based on 7 companies in the industry. Companies in the top quartile (top 25%) have a PEG Ratio significantly above this median, while those in the bottom quartile fall well below. However, PEG Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PEG Ratio mean?
A high PEG Ratio can signal that a stock is expensive relative to its fundamentals. Price-earnings to growth ratio is the ratio of price-earnings to a company's earnings growth rate. View historical data on Clover Health Investments and its competitors. For the Healthcare Plans industry, the median PEG Ratio is 2.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clover Health Investments's current PEG Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clover Health Investments stock overvalued right now?
Based on GuruFocus' analysis, Clover Health Investments (BSP:CLOV34) is currently considered Modestly Overvalued. The stock's GF Value™ is R$20.49, compared to a current price of R$26.19 — trading 27.8% above its estimated fair value. The current PEG Ratio is 0.00. Clover Health Investments' overall GF Score™ is 48/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PEG Ratio calculated?
PEG Ratio is calculated from a company's financial statements. For Clover Health Investments (BSP:CLOV34), the current PEG Ratio is 0.00 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Clover Health Investments (BSP:CLOV34) Overvalued in 2026?
Based on GuruFocus' analysis, Clover Health Investments stock appears to be overvalued.
The current stock price of R$26.19 is trading 27.8% above its estimated GF Value™ of R$20.49.
GuruFocus considers Clover Health Investments to be Modestly Overvalued.
Key valuation signals for BSP:CLOV34:
PEG Ratio: 0.00
GF Value™: R$20.49 vs. price of R$26.19 (27.8% above fair value)
No single metric tells the full story. See the BSP:CLOV34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Clover Health Investments Corp is a healthcare technology company. It focuses on empowering Medicare physicians to proactively manage chronic diseases through its proprietary software platform, Clover Assistant. This cloud-based solution provides personalized insights to physicians, enabling early detection and management of chronic conditions. It operates in one segment: Insurance, through which it offers PPO and HMO plans to Medicare Advantage members in several states.
48GF Score
Get the complete analysis for BSP:CLOV34
PEG Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:CLOV34 has been successfully added to your 
